JAZZ News and Press, Jazz Pharmaceuticals plc From 02/07/24

2024-02-07 07:35:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech investing is not for impatient investors. So why is it attractive to some investors? Ernest Hemingway penned the line “gradually, then suddenly,” referring to how someone ...

2024-02-07 03:41:50 ET More on Jazz Pharmaceuticals Updated View On Jazz Pharmaceuticals' 2025 Goals Jazz Pharmaceuticals' Zanidatamab Promises Growth Amidst Market Undervaluation Jazz Pharma PTSD mid-stage trial fails to meet main goal, stock slips after hours ...

Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program PR Newswire Redx to receive $10 million upfront; potential for up to $870 million in development, regulatory and sales milestone payments in ad...

2024-02-06 10:04:54 ET Summary Zymeworks' share price is moving higher lately, led by an overall recovery of biotech stocks, and possibly by increased investor interest in the company’s emerging antibody-drug conjugate platform. The topline results from the phase 3 trial of...

2024-01-31 13:04:00 ET Summary ZYME's partners, JAZZ and BGNE, are potentially within a year of approval and launch of zanidatamab, a bispecific anti-HER2 antibody. The approval and launch of zanidatamab in multiple markets could generate significant milestones and royalty streams...

2024-01-29 15:17:00 ET Summary Jazz Pharmaceuticals is likely to fall short of its 2025 revenue goal of $5 billion unless it makes a bold M&A move. Despite this, the stock looks undervalued and has the potential to re-rate higher, driven by the growth of Xywav, Rylaze, and Epi...

2024-01-28 02:56:55 ET Summary Avadel Pharmaceuticals has made good progress with the launch of Lumryz, enrolling 1,900 patients and generating $19 million in Q4 net sales. Legal risks from competitor Jazz Pharmaceuticals remain a concern, with ongoing litigation and the potential...

2024-01-23 07:11:07 ET More on Apple Apple Faces Major Potential Risks Apple Stock: The Market Ignores The Obvious Is Everyone Sleeping On Apple's Real Potential In 2024? (Rating Upgrade) Apple said to pay $13.7M fine to Russia over alleged in-app payment abu...

2024-01-19 01:30:00 ET Summary Polaris Capital Management, LLC is a leading global value equity manager, serving the investment needs of institutions and individuals since 1995. Polaris has one of the longest global and international equity track records of any firm presently in opera...

2024-01-18 11:00:00 ET Summary Polaris Capital Management, LLC is a leading global value equity manager, serving the investment needs of institutions and individuals since 1995. Polaris has one of the longest global and international equity track records of any firm presently in opera...